[HTML][HTML] Genetics is of the essence to face NAFLD

M Meroni, M Longo, G Tria, P Dongiovanni - Biomedicines, 2021 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease
worldwide. It is closely related to obesity, insulin resistance (IR) and dyslipidemia so much …

NAFLD: genetics and its clinical implications

D Sharma, P Mandal - Clinics and Research in Hepatology and …, 2022 - Elsevier
Worldwide non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type
of liver disease and its burden increasing at an alarming rate. NAFLD entails steatosis …

[HTML][HTML] Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis

P Dongiovanni, S Romeo, L Valenti - BioMed research international, 2015 - hindawi.com
Liver fat accumulation generally related to systemic insulin resistance characterizes
nonalcoholic fatty liver disease (NAFLD), which in the presence of nonalcoholic …

[HTML][HTML] Novel insights into the genetic landscape of nonalcoholic fatty liver disease

AE Taliento, M Dallio, A Federico, D Prati… - International journal of …, 2019 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), the most common liver disorder worldwide, is
epidemiologically associated with overweight, insulin resistance features and type 2 …

[HTML][HTML] Non-alcoholic fatty liver disease: a narrative review of genetics

CJ Danford, Z Yao, ZG Jiang - Journal of biomedical research, 2018 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver
diseases worldwide. It encompasses a spectrum of disorders ranging from isolated hepatic …

Update on genetics and epigenetics in metabolic associated fatty liver disease

X Zhu, M Xia, X Gao - Therapeutic Advances in …, 2022 - journals.sagepub.com
Nonalcoholic fatty liver disease (NAFLD) is becoming the most frequent chronic liver
disease worldwide. Metabolic (dysfunction) associated fatty liver disease (MAFLD) is …

Genetics of nonalcoholic fatty liver disease: a 2018 update

LVC Valenti, GA Baselli - Current pharmaceutical design, 2018 - ingentaconnect.com
Nonalcoholic fatty liver disease (NAFLD), now the leading cause of liver damage worldwide,
is epidemiologically associated with obesity, insulin resistance and type 2 diabetes, and is a …

Genetics and epigenetics of NAFLD and NASH: Clinical impact

M Eslam, L Valenti, S Romeo - Journal of hepatology, 2018 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common liver
disease worldwide. It encompasses a broad spectrum of conditions, from simple steatosis …

[HTML][HTML] The genetic backgrounds in nonalcoholic fatty liver disease

Y Seko, K Yamaguchi, Y Itoh - Clinical journal of gastroenterology, 2018 - Springer
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can lead to …

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment

P Dongiovanni, QM Anstee… - Current pharmaceutical …, 2013 - ingentaconnect.com
Liver fat deposition related to systemic insulin resistance defines non-alcoholic fatty liver
disease (NAFLD) which, when associated with oxidative hepatocellular damage …